Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway

Authors: Chunming Gu, Yanjun Liu, Zhao Yin, Juhua Yang, Guiping Huang, Xuejiao Zhu, Yumin Li & Jia Fei

Citation: Gu, C., Liu, Y., Yin, Z. Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway. Mol Ther Nucleic Acids. (2019). https://doi.org/10.1016/j.omtn.2019.01.015

Used in this study: B-luc K-562 cancer cell line